320 related articles for article (PubMed ID: 18027869)
21. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
[TBL] [Abstract][Full Text] [Related]
22. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
Lubet RA; Huebner K; Fong LY; Altieri DC; Steele VE; Kopelovich L; Kavanaugh C; Juliana MM; Soong SJ; Grubbs CJ
Carcinogenesis; 2005 Mar; 26(3):571-8. PubMed ID: 15591090
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
Lubet RA; Fischer SM; Steele VE; Juliana MM; Desmond R; Grubbs CJ
Int J Cancer; 2008 Nov; 123(10):2254-9. PubMed ID: 18712722
[TBL] [Abstract][Full Text] [Related]
24. Bladder carcinogenesis in mice induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and N-ethyl-N-(4-hydroxybutyl)-nitrosamine with reference to the effect of cyclophosphamide.
Numoto S; Yoshida M; Otsuka H
Gan; 1981 Oct; 72(5):647-54. PubMed ID: 7327366
[TBL] [Abstract][Full Text] [Related]
25. Commentary on "tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis." He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.: Mutat Res 2012;742(1-2):92-5 [Epub 2011 Dec 4].
Scherr DS
Urol Oncol; 2014 Feb; 32(2):214. PubMed ID: 24445298
[TBL] [Abstract][Full Text] [Related]
26. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
Wanibuchi H; Yamamoto S; Chen H; Yoshida K; Endo G; Hori T; Fukushima S
Carcinogenesis; 1996 Nov; 17(11):2435-9. PubMed ID: 8968060
[TBL] [Abstract][Full Text] [Related]
27. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
[TBL] [Abstract][Full Text] [Related]
28. Organ differences in the impact of p27(kip1) deficiency on carcinogenesis induced by N-methyl-N-nitrosourea.
Ogawa K; Murasaki T; Sugiura S; Nakanishi M; Shirai T
J Appl Toxicol; 2013 Jun; 33(6):471-9. PubMed ID: 22183835
[TBL] [Abstract][Full Text] [Related]
29. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
Irving CC; Murphy WM; Daniel DS
J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920
[TBL] [Abstract][Full Text] [Related]
30. Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.
Iida K; Itoh K; Maher JM; Kumagai Y; Oyasu R; Mori Y; Shimazui T; Akaza H; Yamamoto M
Carcinogenesis; 2007 Nov; 28(11):2398-403. PubMed ID: 17602169
[TBL] [Abstract][Full Text] [Related]
31. Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice.
Wei M; Wanibuchi H; Morimura K; Salim EI; Moku M; Doi K; Mitsuhashi M; Masuda C; Shen J; Kinoshita A; Fukushima S
Anticancer Res; 2004; 24(2B):785-90. PubMed ID: 15161027
[TBL] [Abstract][Full Text] [Related]
32. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Miyazawa K; Miyamoto S; Suzuki R; Yasui Y; Ikeda R; Kohno H; Yano M; Tanaka T; Hata K; Suzuki K
Oncol Rep; 2007 Feb; 17(2):297-304. PubMed ID: 17203164
[TBL] [Abstract][Full Text] [Related]
33. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Tatematsu M; Lurie AG; Rippey RM; Conran PB; Arai M; Fukushima S; Ito N
Cancer Res; 1984 Jan; 44(1):278-84. PubMed ID: 6690039
[TBL] [Abstract][Full Text] [Related]
34. Review: BBN as an urothelial carcinogen.
Vasconcelos-Nóbrega C; Colaço A; Lopes C; Oliveira PA
In Vivo; 2012; 26(4):727-39. PubMed ID: 22773588
[TBL] [Abstract][Full Text] [Related]
35. Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.
Baffa R; Fassan M; Sevignani C; Vecchione A; Ishii H; Giarnieri E; Iozzo RV; Gomella LG; Croce CM
Carcinogenesis; 2008 Apr; 29(4):846-8. PubMed ID: 18192690
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
[TBL] [Abstract][Full Text] [Related]
37. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
Nakanowatari J; Fukushima S; Imaida K; Ito N; Nagase S
Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
[TBL] [Abstract][Full Text] [Related]
38. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
[TBL] [Abstract][Full Text] [Related]
39. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
[TBL] [Abstract][Full Text] [Related]
40. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
Szende B; Jeney A; Institoris L
Acta Morphol Hung; 1992; 40(1-4):187-93. PubMed ID: 1365762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
